Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
3 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
4件: BRAF, FLT3, KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
5 Acute myeloid leukemia 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
7 Acute myeloid leukemia 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
9 Acute myeloid leukemia 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
10 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
12 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
13 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
14 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
15 Acute myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
16 Acute myeloid leukemia 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
17 Acute myeloid leukemia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
18 Acute myeloid leukemia 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
19 Adherens junction 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
20 Adherens junction 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
21 Adherens junction 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
22 Adherens junction 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
23 Adherens junction 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
24 Adherens junction 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
25 Adherens junction 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
26 Adherens junction 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
27 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
28 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
29 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
30 Adipocytokine signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
31 Adipocytokine signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Adipocytokine signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
33 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lamotrigine 💬 Lamotrigine 6件: 13, 34, 38, 113, 114, 144 💬
34 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
35 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
36 Adrenergic signaling in cardiomyocytes 💬
1件: SCN5A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
37 African trypanosomiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
38 African trypanosomiasis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
39 African trypanosomiasis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
40 AGE-RAGE signaling pathway in diabetic complications 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
41 AGE-RAGE signaling pathway in diabetic complications 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
42 AGE-RAGE signaling pathway in diabetic complications 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
43 AGE-RAGE signaling pathway in diabetic complications 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
44 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
45 AGE-RAGE signaling pathway in diabetic complications 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
46 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
47 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
48 Alanine, aspartate and glutamate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
49 Alcoholic liver disease 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
50 Alcoholic liver disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
51 Alcoholic liver disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
52 Alcoholism 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
53 Alcoholism 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
54 Alcoholism 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
55 Alcoholism 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
56 Alcoholism 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
57 Alcoholism 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
58 Alcoholism 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
59 Alcoholism 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
60 Alcoholism 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
61 Alcoholism 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
62 Alcoholism 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
63 Alcoholism 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
64 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
65 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
66 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
67 Allograft rejection 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
68 Allograft rejection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
69 Allograft rejection 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
70 Alzheimer disease 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
71 Alzheimer disease 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
72 Alzheimer disease 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
73 Alzheimer disease 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
74 Alzheimer disease 💬
3件: CHRM1, CHRM3, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
75 Alzheimer disease 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
76 Alzheimer disease 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
77 Alzheimer disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
78 Alzheimer disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
79 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
80 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
81 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
82 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
83 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
84 Alzheimer disease 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
85 Alzheimer disease 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
86 Alzheimer disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
87 Alzheimer disease 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
88 Alzheimer disease 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
89 Alzheimer disease 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
90 Alzheimer disease 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
91 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
92 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
93 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
94 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
95 Alzheimer disease 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
96 Alzheimer disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
97 Alzheimer disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
98 Alzheimer disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
99 Alzheimer disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
100 Alzheimer disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
101 Amoebiasis 💬
4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102 Amoebiasis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
103 Amoebiasis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
104 Amphetamine addiction 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
105 Amphetamine addiction 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
106 AMPK signaling pathway 💬
1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
107 AMPK signaling pathway 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
108 AMPK signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
109 AMPK signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
110 AMPK signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
111 Amyotrophic lateral sclerosis 💬
1件: ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
112 Amyotrophic lateral sclerosis 💬
1件: ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
113 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
114 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
115 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
116 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
117 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
118 Amyotrophic lateral sclerosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
119 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
120 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
121 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
122 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
123 Antigen processing and presentation 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
124 Antigen processing and presentation 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
125 Antigen processing and presentation 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
126 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
127 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
128 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
129 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
130 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
131 Apelin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
132 Apelin signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
133 Apelin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
134 Apelin signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
135 Apelin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
136 Apelin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
137 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
138 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
139 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
140 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
141 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
142 Apoptosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
143 Apoptosis 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
144 Apoptosis 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
145 Apoptosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
146 Apoptosis 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
147 Apoptosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
148 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
149 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
150 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
151 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
152 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
153 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
154 Arachidonic acid metabolism 💬
2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
155 Arachidonic acid metabolism 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
156 Asthma 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
157 Asthma 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
158 Asthma 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
159 Autoimmune thyroid disease 💬
1件: IL10 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
160 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
161 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
162 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
163 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
164 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
165 Autophagy - animal 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
166 Autophagy - animal 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
167 Autophagy - animal 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
168 Autophagy - animal 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
169 Autophagy - animal 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
170 Autophagy - animal 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
171 Autophagy - other 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
172 Autophagy - other 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
173 Autophagy - other 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
174 Axon guidance 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
175 Axon guidance 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
176 Axon guidance 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
177 Axon guidance 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
178 Axon guidance 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
179 Axon guidance 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
180 Axon guidance 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
181 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
182 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
183 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
184 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
185 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
186 B cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
187 B cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
188 B cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
189 Bacterial invasion of epithelial cells 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
190 Bacterial invasion of epithelial cells 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
191 beta-Alanine metabolism 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
192 beta-Alanine metabolism 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
193 beta-Alanine metabolism 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
194 Bile secretion 💬
1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
195 Bile secretion 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
196 Bladder cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
197 Bladder cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
198 Bladder cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
199 Bladder cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
200 Bladder cancer 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
201 Bladder cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
202 Bladder cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
203 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
204 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
205 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
206 Bladder cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
207 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
208 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
209 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
210 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
211 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
212 Bladder cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
213 Bladder cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
214 Bladder cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
215 Breast cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
216 Breast cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
217 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
218 Breast cancer 💬
4件: BRAF, FLT4, KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
219 Breast cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
220 Breast cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
221 Breast cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
222 Breast cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
223 Breast cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
224 Breast cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
225 Breast cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
226 Breast cancer 💬
1件: FLT4 💬 Axitinib 💬 Axitinib 1件: 34 💬
227 Breast cancer 💬
1件: FLT4 💬 Cediranib 💬 Cediranib 1件: 34 💬
228 Breast cancer 💬
1件: FLT4 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
229 Breast cancer 💬
2件: FLT4, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
230 Breast cancer 💬
2件: FLT4, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
231 Breast cancer 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
232 Breast cancer 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
233 Breast cancer 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
234 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
235 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
236 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
237 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
238 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
239 Breast cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
240 Breast cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
241 Breast cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
242 Breast cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
243 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
244 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
245 Butanoate metabolism 💬
4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
246 C-type lectin receptor signaling pathway 💬
4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
247 C-type lectin receptor signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
248 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
249 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
250 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
251 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
252 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
253 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
254 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
255 C-type lectin receptor signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
256 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
257 C-type lectin receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
258 C-type lectin receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
259 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
260 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
261 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
262 Calcium signaling pathway 💬
4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
263 Calcium signaling pathway 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
264 Calcium signaling pathway 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
265 Calcium signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
266 Calcium signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
267 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
268 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
269 Calcium signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
270 Calcium signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
271 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
272 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
273 Calcium signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
274 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
275 Calcium signaling pathway 💬
6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
276 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
277 Calcium signaling pathway 💬
4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
278 Calcium signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
279 Calcium signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
280 Calcium signaling pathway 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
281 Calcium signaling pathway 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
282 Calcium signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
283 Calcium signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
284 Calcium signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
285 cAMP signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
286 cAMP signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
287 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
288 cAMP signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
289 cAMP signaling pathway 💬
2件: CHRM1, CHRM2 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
290 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
291 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
292 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
293 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
294 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
295 cAMP signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
296 Cell cycle 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
297 Cell cycle 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
298 Cell cycle 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
299 Cell cycle 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
300 Cellular senescence 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
301 Cellular senescence 💬
2件: IL1A, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
302 Cellular senescence 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
303 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
304 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
305 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
306 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
307 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
308 Cellular senescence 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
309 Cellular senescence 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
310 Cellular senescence 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
311 Cellular senescence 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
312 Cellular senescence 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
313 Cellular senescence 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
314 Central carbon metabolism in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
315 Central carbon metabolism in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
316 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
317 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
318 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
319 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
320 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
321 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
322 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
323 Central carbon metabolism in cancer 💬
5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
324 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
325 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
326 Central carbon metabolism in cancer 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
327 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
328 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
329 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
330 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
331 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
332 Central carbon metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
333 Central carbon metabolism in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
334 Central carbon metabolism in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
335 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
336 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
337 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
338 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
339 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
340 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
341 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
342 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
343 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
344 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
345 cGMP-PKG signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
346 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
347 cGMP-PKG signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
348 Chagas disease 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
349 Chagas disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
350 Chagas disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
351 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
352 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
353 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
354 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
355 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
356 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
357 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
358 Chemical carcinogenesis - DNA adducts 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
359 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
360 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
361 Chemical carcinogenesis - reactive oxygen species 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
362 Chemical carcinogenesis - reactive oxygen species 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
363 Chemical carcinogenesis - reactive oxygen species 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
364 Chemical carcinogenesis - reactive oxygen species 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
365 Chemical carcinogenesis - reactive oxygen species 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
366 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
367 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
368 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
369 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
370 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
371 Chemical carcinogenesis - reactive oxygen species 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
372 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
373 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
374 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
375 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
376 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
377 Chemical carcinogenesis - reactive oxygen species 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
378 Chemical carcinogenesis - reactive oxygen species 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
379 Chemical carcinogenesis - reactive oxygen species 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
380 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
381 Chemical carcinogenesis - reactive oxygen species 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
382 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
383 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
384 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
385 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
386 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
387 Chemical carcinogenesis - receptor activation 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
388 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
389 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
390 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
391 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
392 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
393 Chemical carcinogenesis - receptor activation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
394 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
395 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
396 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
397 Chemical carcinogenesis - receptor activation 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
398 Chemical carcinogenesis - receptor activation 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
399 Chemical carcinogenesis - receptor activation 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
400 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
401 Chemical carcinogenesis - receptor activation 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
402 Chemokine signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
403 Chemokine signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
404 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
405 Chemokine signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
406 Chemokine signaling pathway 💬
1件: CCL2 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
407 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
408 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
409 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
410 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
411 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
412 Chemokine signaling pathway 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
413 Choline metabolism in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
414 Choline metabolism in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
415 Choline metabolism in cancer 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
416 Choline metabolism in cancer 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
417 Choline metabolism in cancer 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
418 Choline metabolism in cancer 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
419 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
420 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
421 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
422 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
423 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
424 Choline metabolism in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
425 Choline metabolism in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
426 Choline metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
427 Choline metabolism in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
428 Choline metabolism in cancer 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
429 Choline metabolism in cancer 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
430 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
431 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
432 Choline metabolism in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
433 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
434 Choline metabolism in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
435 Cholinergic synapse 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
436 Cholinergic synapse 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
437 Cholinergic synapse 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
438 Cholinergic synapse 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
439 Cholinergic synapse 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
440 Cholinergic synapse 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
441 Cholinergic synapse 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
442 Cholinergic synapse 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
443 Cholinergic synapse 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
444 Chronic myeloid leukemia 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
445 Chronic myeloid leukemia 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
446 Chronic myeloid leukemia 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
447 Chronic myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
448 Chronic myeloid leukemia 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
449 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
450 Chronic myeloid leukemia 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
451 Chronic myeloid leukemia 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
452 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
453 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
454 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
455 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
456 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
457 Chronic myeloid leukemia 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
458 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
459 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
460 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
461 Cocaine addiction 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
462 Cocaine addiction 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
463 Colorectal cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
464 Colorectal cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
465 Colorectal cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
466 Colorectal cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
467 Colorectal cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
468 Colorectal cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
469 Colorectal cancer 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
470 Colorectal cancer 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
471 Colorectal cancer 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
472 Colorectal cancer 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
473 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
474 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
475 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
476 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
477 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
478 Colorectal cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
479 Colorectal cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
480 Colorectal cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
481 Colorectal cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
482 Coronavirus disease - COVID-19 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
483 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
484 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
485 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
486 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
487 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
488 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
489 Coronavirus disease - COVID-19 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
490 Coronavirus disease - COVID-19 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
491 Coronavirus disease - COVID-19 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
492 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
493 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
494 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
495 Cushing syndrome 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
496 Cushing syndrome 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
497 Cushing syndrome 💬
1件: BRAF 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
498 Cushing syndrome 💬
1件: BRAF 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
499 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
500 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
501 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
502 Cushing syndrome 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
503 Cushing syndrome 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
504 Cushing syndrome 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
505 Cushing syndrome 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
506 Cushing syndrome 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
507 Cushing syndrome 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
508 Cushing syndrome 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
509 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
510 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
511 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
512 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
513 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
514 Cushing syndrome 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
515 Cysteine and methionine metabolism 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
516 Cytokine-cytokine receptor interaction 💬
6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
517 Cytokine-cytokine receptor interaction 💬
1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
518 Cytokine-cytokine receptor interaction 💬
1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
519 Cytokine-cytokine receptor interaction 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 29件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
520 Cytokine-cytokine receptor interaction 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
521 Cytokine-cytokine receptor interaction 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
522 Cytosolic DNA-sensing pathway 💬
2件: IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
523 Cytosolic DNA-sensing pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
524 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
525 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
526 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
527 Dilated cardiomyopathy 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
528 Dilated cardiomyopathy 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
529 Dilated cardiomyopathy 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
530 Dopaminergic synapse 💬
1件: SCN1A 💬 Lamotrigine 💬 Lamotrigine 6件: 13, 34, 38, 113, 114, 144 💬
531 Dopaminergic synapse 💬
1件: SCN1A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
532 Dopaminergic synapse 💬
1件: SCN1A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
533 Dopaminergic synapse 💬
1件: SCN1A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
534 Dopaminergic synapse 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
535 Dopaminergic synapse 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
536 Drug metabolism - other enzymes 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
537 Drug metabolism - other enzymes 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
538 ECM-receptor interaction 💬
1件: SV2 💬 Levetiracetam 💬 Levetiracetam 7件:  2 ,  4 ,  6 , 13, 34, 149, 307 💬
539 Efferocytosis 💬
1件: AXL 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
540 Efferocytosis 💬
1件: AXL 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
541 Efferocytosis 💬
1件: DNMT3A 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
542 Efferocytosis 💬
1件: IL10 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
543 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
544 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
545 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
546 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
547 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
548 Efferocytosis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
549 Efferocytosis 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
550 Efferocytosis 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
551 Efferocytosis 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
552 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
553 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
554 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
555 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
556 Efferocytosis 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
557 Endocrine and other factor-regulated calcium reabsorption 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
558 Endocytosis 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
559 Endocytosis 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
560 Endocytosis 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
561 Endocytosis 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
562 Endocytosis 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
563 Endocytosis 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
564 Endocytosis 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
565 Endocytosis 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
566 Endocytosis 💬
1件: PDGFRA 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
567 Endocytosis 💬
1件: PDGFRA 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
568 Endocytosis 💬
1件: PDGFRA 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
569 Endometrial cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
570 Endometrial cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
571 Endometrial cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
572 Endometrial cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
573 Endometrial cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
574 Endometrial cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
575 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
576 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
577 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
578 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
579 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
580 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
581 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
582 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
583 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
584 Endometrial cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
585 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
586 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
587 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
588 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
589 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
590 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
591 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
592 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
593 Epstein-Barr virus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
594 Epstein-Barr virus infection 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
595 Epstein-Barr virus infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
596 Epstein-Barr virus infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
597 ErbB signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
598 ErbB signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
599 ErbB signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
600 ErbB signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
601 ErbB signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
602 ErbB signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
603 ErbB signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
604 ErbB signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
605 ErbB signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
606 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
607 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
608 ErbB signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
609 ErbB signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
610 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
611 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
612 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
613 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
614 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
615 ErbB signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
616 ErbB signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
617 ErbB signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
618 ErbB signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
619 Estrogen signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
620 Estrogen signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
621 Estrogen signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
622 Estrogen signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
623 Estrogen signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
624 Estrogen signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
625 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
626 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
627 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
628 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
629 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
630 Estrogen signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
631 Estrogen signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
632 Estrogen signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
633 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
634 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
635 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
636 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
637 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
638 Fc epsilon RI signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
639 Fc epsilon RI signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
640 Fc epsilon RI signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
641 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
642 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
643 Fc epsilon RI signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
644 Fc gamma R-mediated phagocytosis 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
645 Fc gamma R-mediated phagocytosis 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
646 Fc gamma R-mediated phagocytosis 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
647 Fc gamma R-mediated phagocytosis 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
648 Fc gamma R-mediated phagocytosis 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
649 Fc gamma R-mediated phagocytosis 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
650 Fc gamma R-mediated phagocytosis 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
651 Fc gamma R-mediated phagocytosis 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
652 Fluid shear stress and atherosclerosis 💬
4件: CCL2, IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
653 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
654 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
655 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
656 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
657 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
658 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
659 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
660 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
661 Fluid shear stress and atherosclerosis 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
662 Fluid shear stress and atherosclerosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
663 Fluid shear stress and atherosclerosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
664 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
665 Fluid shear stress and atherosclerosis 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
666 Focal adhesion 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
667 Focal adhesion 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
668 Focal adhesion 💬
5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
669 Focal adhesion 💬
5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
670 Focal adhesion 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
671 Focal adhesion 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
672 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
673 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
674 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
675 Focal adhesion 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
676 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
677 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
678 Focal adhesion 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
679 Focal adhesion 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
680 Focal adhesion 💬
5件: FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
681 Focal adhesion 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
682 Focal adhesion 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
683 Focal adhesion 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
684 Focal adhesion 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
685 Focal adhesion 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
686 Focal adhesion 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
687 Focal adhesion 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
688 Focal adhesion 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
689 Focal adhesion 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
690 Focal adhesion 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
691 Focal adhesion 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
692 Focal adhesion 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
693 Focal adhesion 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
694 Folate biosynthesis 💬
2件: DHFR, DHFR 💬 Methotrexate sodium 💬 Methotrexate 39件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
695 Folate biosynthesis 💬
2件: DHFR, DHFR 💬 Methotrexate 💬 Methotrexate 39件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
696 Folate transport and metabolism 💬
2件: DHFR, DHFR 💬 Methotrexate 💬 Methotrexate 39件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
697 Folate transport and metabolism 💬
2件: DHFR, DHFR 💬 Methotrexate sodium 💬 Methotrexate 39件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
698 FoxO signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
699 FoxO signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
700 FoxO signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
701 FoxO signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
702 FoxO signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
703 FoxO signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
704 FoxO signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
705 FoxO signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
706 FoxO signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
707 FoxO signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
708 FoxO signaling pathway 💬
2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
709 FoxO signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
710 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
711 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
712 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
713 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
714 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
715 FoxO signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
716 GABAergic synapse 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
717 GABAergic synapse 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
718 GABAergic synapse 💬
3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
719 GABAergic synapse 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
720 Gap junction 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
721 Gap junction 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
722 Gap junction 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
723 Gap junction 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
724 Gap junction 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
725 Gap junction 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
726 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
727 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
728 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
729 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
730 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
731 Gap junction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
732 Gap junction 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
733 Gap junction 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
734 Gap junction 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
735 Gap junction 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
736 Gap junction 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
737 Gap junction 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
738 Gap junction 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
739 Gap junction 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
740 Gap junction 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
741 Gap junction 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
742 Gap junction 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
743 Gastric acid secretion 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
744 Gastric acid secretion 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
745 Gastric acid secretion 💬
1件: CHRM3 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
746 Gastric cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
747 Gastric cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
748 Gastric cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
749 Gastric cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
750 Gastric cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
751 Gastric cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
752 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
753 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
754 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
755 Gastric cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
756 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
757 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
758 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
759 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
760 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
761 Gastric cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
762 Gastric cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
763 Gastric cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
764 Gastric cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
765 Gastric cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
766 Gastric cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
767 Glioma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
768 Glioma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
769 Glioma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
770 Glioma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
771 Glioma 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
772 Glioma 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
773 Glioma 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
774 Glioma 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
775 Glioma 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
776 Glioma 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
777 Glioma 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
778 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
779 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
780 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
781 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
782 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
783 Glioma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
784 Glioma 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
785 Glioma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
786 Glioma 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
787 Glioma 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
788 Glioma 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
789 Glioma 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
790 Glioma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
791 Glioma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
792 Glutathione metabolism 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
793 Glutathione metabolism 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
794 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
795 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
796 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
797 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
798 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
799 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
800 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
801 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
802 GnRH secretion 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
803 GnRH secretion 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
804 GnRH secretion 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
805 GnRH signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
806 GnRH signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
807 GnRH signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
808 GnRH signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
809 GnRH signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
810 GnRH signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
811 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
812 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
813 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
814 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
815 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
816 GnRH signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
817 GnRH signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
818 GnRH signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
819 Graft-versus-host disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
820 Graft-versus-host disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
821 Graft-versus-host disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
822 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
823 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
824 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
825 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
826 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
827 Growth hormone synthesis, secretion and action 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
828 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
829 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
830 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
831 Growth hormone synthesis, secretion and action 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
832 Growth hormone synthesis, secretion and action 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
833 Hematopoietic cell lineage 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
834 Hematopoietic cell lineage 💬
3件: CSF1R, FLT3, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
835 Hematopoietic cell lineage 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 29件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
836 Hematopoietic cell lineage 💬
2件: FLT3, KIT 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
837 Hematopoietic cell lineage 💬
2件: FLT3, KIT 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
838 Hematopoietic cell lineage 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
839 Hematopoietic cell lineage 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
840 Hematopoietic cell lineage 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
841 Hematopoietic cell lineage 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
842 Hematopoietic cell lineage 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
843 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Rituximab 💬 Rituximab 52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
844 Hematopoietic cell lineage 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
845 Hepatitis B 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
846 Hepatitis B 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
847 Hepatitis B 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
848 Hepatitis B 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
849 Hepatitis B 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
850 Hepatitis B 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
851 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
852 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
853 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
854 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
855 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
856 Hepatitis B 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
857 Hepatitis B 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
858 Hepatitis C 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
859 Hepatitis C 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
860 Hepatitis C 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
861 Hepatitis C 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
862 Hepatitis C 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
863 Hepatitis C 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
864 Hepatitis C 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
865 Hepatitis C 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
866 Hepatitis C 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
867 Hepatitis C 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
868 Hepatitis C 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
869 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
870 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
871 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
872 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
873 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
874 Hepatitis C 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
875 Hepatitis C 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
876 Hepatitis C 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
877 Hepatitis C 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
878 Hepatocellular carcinoma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
879 Hepatocellular carcinoma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
880 Hepatocellular carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
881 Hepatocellular carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
882 Hepatocellular carcinoma 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
883 Hepatocellular carcinoma 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
884 Hepatocellular carcinoma 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
885 Hepatocellular carcinoma 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
886 Hepatocellular carcinoma 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
887 Hepatocellular carcinoma 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
888 Hepatocellular carcinoma 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
889 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
890 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
891 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
892 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
893 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
894 Hepatocellular carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
895 Hepatocellular carcinoma 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
896 Hepatocellular carcinoma 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
897 Hepatocellular carcinoma 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
898 Hepatocellular carcinoma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
899 Hepatocellular carcinoma 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
900 Herpes simplex virus 1 infection 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
901 Herpes simplex virus 1 infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
902 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
903 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
904 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
905 Herpes simplex virus 1 infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
906 HIF-1 signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
907 HIF-1 signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
908 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
909 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
910 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
911 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
912 HIF-1 signaling pathway 💬
1件: FLT1 💬 Axitinib 💬 Axitinib 1件: 34 💬
913 HIF-1 signaling pathway 💬
1件: FLT1 💬 Cediranib 💬 Cediranib 1件: 34 💬
914 HIF-1 signaling pathway 💬
1件: FLT1 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
915 HIF-1 signaling pathway 💬
1件: FLT1 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
916 HIF-1 signaling pathway 💬
1件: FLT1 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
917 HIF-1 signaling pathway 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
918 HIF-1 signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
919 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
920 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
921 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
922 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
923 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
924 HIF-1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
925 HIF-1 signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
926 HIF-1 signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
927 HIF-1 signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
928 HIF-1 signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
929 HIF-1 signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
930 Hormone signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
931 Hormone signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
932 Human cytomegalovirus infection 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
933 Human cytomegalovirus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
934 Human cytomegalovirus infection 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
935 Human cytomegalovirus infection 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
936 Human cytomegalovirus infection 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
937 Human cytomegalovirus infection 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
938 Human cytomegalovirus infection 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
939 Human cytomegalovirus infection 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
940 Human cytomegalovirus infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
941 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
942 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
943 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
944 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
945 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
946 Human cytomegalovirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
947 Human cytomegalovirus infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
948 Human cytomegalovirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
949 Human cytomegalovirus infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
950 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
951 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
952 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
953 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
954 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
955 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
956 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
957 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
958 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
959 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
960 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
961 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
962 Human cytomegalovirus infection 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
963 Human cytomegalovirus infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
964 Human cytomegalovirus infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
965 Human cytomegalovirus infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
966 Human cytomegalovirus infection 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
967 Human cytomegalovirus infection 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
968 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
969 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
970 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
971 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
972 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
973 Human immunodeficiency virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
974 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
975 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
976 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
977 Human immunodeficiency virus 1 infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
978 Human immunodeficiency virus 1 infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
979 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
980 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
981 Human immunodeficiency virus 1 infection 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
982 Human papillomavirus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
983 Human papillomavirus infection 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
984 Human papillomavirus infection 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
985 Human papillomavirus infection 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
986 Human papillomavirus infection 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
987 Human papillomavirus infection 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
988 Human papillomavirus infection 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
989 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
990 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
991 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
992 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
993 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
994 Human papillomavirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
995 Human papillomavirus infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
996 Human papillomavirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
997 Human papillomavirus infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
998 Human papillomavirus infection 💬
1件: PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
999 Human papillomavirus infection 💬
1件: PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1000 Human papillomavirus infection 💬
1件: PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1001 Human papillomavirus infection 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1002 Human papillomavirus infection 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1003 Human papillomavirus infection 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1004 Human papillomavirus infection 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1005 Human papillomavirus infection 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1006 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1007 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1008 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1009 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1010 Human papillomavirus infection 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1011 Human papillomavirus infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1012 Human papillomavirus infection 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1013 Human papillomavirus infection 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1014 Human papillomavirus infection 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1015 Human papillomavirus infection 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1016 Human T-cell leukemia virus 1 infection 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1017 Human T-cell leukemia virus 1 infection 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1018 Human T-cell leukemia virus 1 infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1019 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1020 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1021 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1022 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1023 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1024 Human T-cell leukemia virus 1 infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1025 Human T-cell leukemia virus 1 infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1026 Huntington disease 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1027 Huntington disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1028 Huntington disease 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1029 Huntington disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1030 Huntington disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1031 Huntington disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1032 Huntington disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1033 Hypertrophic cardiomyopathy 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1034 Hypertrophic cardiomyopathy 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1035 Hypertrophic cardiomyopathy 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1036 IL-17 signaling pathway 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1037 IL-17 signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1038 IL-17 signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1039 IL-17 signaling pathway 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1040 IL-17 signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1041 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1042 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1043 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1044 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1045 IL-17 signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1046 IL-17 signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1047 Inflammatory bowel disease 💬
5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1048 Inflammatory bowel disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1049 Inflammatory bowel disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1050 Inflammatory mediator regulation of TRP channels 💬
1件: IL1B 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1051 Influenza A 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1052 Influenza A 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1053 Influenza A 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1054 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1055 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1056 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1057 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1058 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1059 Influenza A 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1060 Influenza A 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1061 Influenza A 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1062 Influenza A 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1063 Influenza A 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1064 Insulin resistance 💬
2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1065 Insulin resistance 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1066 Insulin resistance 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1067 Insulin resistance 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1068 Insulin resistance 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1069 Insulin resistance 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1070 Insulin secretion 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1071 Insulin secretion 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1072 Insulin secretion 💬
1件: CHRM3 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1073 Insulin signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1074 Insulin signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1075 Insulin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1076 Insulin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1077 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1078 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1079 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1080 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1081 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1082 Insulin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1083 Insulin signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1084 Insulin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1085 Insulin signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1086 Intestinal immune network for IgA production 💬
2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1087 Intestinal immune network for IgA production 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1088 JAK-STAT signaling pathway 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 29件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1089 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1090 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1091 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1092 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1093 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1094 JAK-STAT signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1095 JAK-STAT signaling pathway 💬
2件: IL10, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1096 JAK-STAT signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1097 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1098 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1099 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1100 JAK-STAT signaling pathway 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1101 JAK-STAT signaling pathway 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1102 JAK-STAT signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1103 JAK-STAT signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1104 JAK-STAT signaling pathway 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1105 JAK-STAT signaling pathway 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1106 JAK-STAT signaling pathway 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1107 Kaposi sarcoma-associated herpesvirus infection 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1108 Kaposi sarcoma-associated herpesvirus infection 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1109 Kaposi sarcoma-associated herpesvirus infection 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1110 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1111 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1112 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1113 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1114 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1115 Kaposi sarcoma-associated herpesvirus infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1116 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1117 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1118 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1119 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1120 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1121 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1122 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1123 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1124 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1125 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1126 Kaposi sarcoma-associated herpesvirus infection 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1127 Kaposi sarcoma-associated herpesvirus infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1128 Kaposi sarcoma-associated herpesvirus infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1129 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1130 Kaposi sarcoma-associated herpesvirus infection 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1131 Legionellosis 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1132 Legionellosis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1133 Legionellosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1134 Leishmaniasis 💬
4件: IL10, IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1135 Leishmaniasis 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1136 Leishmaniasis 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1137 Leishmaniasis 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1138 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1139 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1140 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1141 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1142 Leishmaniasis 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1143 Leishmaniasis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1144 Leishmaniasis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1145 Lipid and atherosclerosis 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1146 Lipid and atherosclerosis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1147 Lipid and atherosclerosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1148 Long-term depression 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1149 Long-term depression 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1150 Long-term depression 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1151 Long-term depression 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1152 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1153 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1154 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1155 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1156 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1157 Long-term depression 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1158 Long-term potentiation 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1159 Long-term potentiation 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1160 Long-term potentiation 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1161 Long-term potentiation 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1162 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1163 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1164 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1165 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1166 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1167 Long-term potentiation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1168 Longevity regulating pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1169 Longevity regulating pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1170 Longevity regulating pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1171 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1172 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1173 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1174 Malaria 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1175 Malaria 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1176 Malaria 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1177 Malaria 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1178 Malaria 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1179 MAPK signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1180 MAPK signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1181 MAPK signaling pathway 💬
8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1182 MAPK signaling pathway 💬
8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1183 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
1184 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
1185 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
1186 MAPK signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1187 MAPK signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1188 MAPK signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1189 MAPK signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1190 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1191 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1192 MAPK signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
1193 MAPK signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1194 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1195 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1196 MAPK signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1197 MAPK signaling pathway 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1198 MAPK signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1199 MAPK signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1200 MAPK signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1201 MAPK signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1202 MAPK signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1203 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1204 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1205 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1206 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1207 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1208 MAPK signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1209 MAPK signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1210 MAPK signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1211 MAPK signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1212 MAPK signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1213 Measles 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1214 Measles 💬
3件: IL1A, IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1215 Measles 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1216 Measles 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1217 Melanogenesis 💬
1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1218 Melanogenesis 💬
1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1219 Melanogenesis 💬
1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1220 Melanogenesis 💬
1件: KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1221 Melanogenesis 💬
1件: KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1222 Melanogenesis 💬
2件: KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1223 Melanogenesis 💬
2件: KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1224 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1225 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1226 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1227 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1228 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1229 Melanogenesis 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1230 Melanoma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1231 Melanoma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1232 Melanoma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1233 Melanoma 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1234 Melanoma 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1235 Melanoma 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1236 Melanoma 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1237 Melanoma 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1238 Melanoma 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1239 Melanoma 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1240 Melanoma 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1241 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1242 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1243 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1244 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1245 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1246 Melanoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1247 Melanoma 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1248 Melanoma 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1249 Melanoma 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1250 Melanoma 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1251 Melanoma 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1252 Melanoma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1253 Melanoma 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1254 MicroRNAs in cancer 💬
2件: ABL1, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1255 MicroRNAs in cancer 💬
2件: ABL1, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1256 MicroRNAs in cancer 💬
3件: ABL1, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1257 MicroRNAs in cancer 💬
1件: CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1258 MicroRNAs in cancer 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
1259 MicroRNAs in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1260 MicroRNAs in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1261 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1262 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1263 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1264 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1265 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1266 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1267 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1268 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1269 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1270 MicroRNAs in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1271 MicroRNAs in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1272 MicroRNAs in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1273 MicroRNAs in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1274 MicroRNAs in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1275 MicroRNAs in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1276 MicroRNAs in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1277 MicroRNAs in cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1278 MicroRNAs in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1279 MicroRNAs in cancer 💬
2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1280 MicroRNAs in cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1281 MicroRNAs in cancer 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1282 MicroRNAs in cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1283 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1284 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1285 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1286 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1287 MicroRNAs in cancer 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1288 MicroRNAs in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1289 MicroRNAs in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1290 Mineral absorption 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
1291 Morphine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1292 Motor proteins 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1293 Motor proteins 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1294 Motor proteins 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1295 Motor proteins 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1296 mTOR signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1297 mTOR signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1298 mTOR signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1299 mTOR signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1300 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1301 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1302 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1303 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1304 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1305 mTOR signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1306 mTOR signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1307 mTOR signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1308 mTOR signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1309 mTOR signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1310 mTOR signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1311 mTOR signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1312 Natural killer cell mediated cytotoxicity 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1313 Natural killer cell mediated cytotoxicity 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1314 Natural killer cell mediated cytotoxicity 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1315 Natural killer cell mediated cytotoxicity 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1316 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1317 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1318 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1319 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1320 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1321 Natural killer cell mediated cytotoxicity 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1322 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1323 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1324 Natural killer cell mediated cytotoxicity 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1325 Necroptosis 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1326 Necroptosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1327 Necroptosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1328 Neuroactive ligand signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1329 Neuroactive ligand signaling 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1330 Neuroactive ligand signaling 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1331 Neuroactive ligand signaling 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1332 Neuroactive ligand signaling 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1333 Neuroactive ligand signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1334 Neuroactive ligand signaling 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1335 Neuroactive ligand signaling 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1336 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1337 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
1338 Neuroactive ligand-receptor interaction 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1339 Neuroactive ligand-receptor interaction 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1340 Neuroactive ligand-receptor interaction 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1341 Neuroactive ligand-receptor interaction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1342 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1343 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1344 Neurotrophin signaling pathway 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1345 Neurotrophin signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1346 Neurotrophin signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1347 Neurotrophin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1348 Neurotrophin signaling pathway 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1349 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1350 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1351 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1352 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1353 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1354 Neurotrophin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1355 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1356 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1357 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1358 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1359 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1360 Neutrophil extracellular trap formation 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1361 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1362 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1363 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1364 Neutrophil extracellular trap formation 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1365 Neutrophil extracellular trap formation 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1366 Neutrophil extracellular trap formation 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
1367 NF-kappa B signaling pathway 💬
2件: IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1368 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1369 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1370 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1371 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1372 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1373 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1374 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1375 NF-kappa B signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1376 NF-kappa B signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1377 NF-kappa B signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1378 Nicotine addiction 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1379 NOD-like receptor signaling pathway 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1380 NOD-like receptor signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1381 NOD-like receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1382 Non-alcoholic fatty liver disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1383 Non-alcoholic fatty liver disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1384 Non-alcoholic fatty liver disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1385 Non-small cell lung cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬
1386 Non-small cell lung cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 2件:  2 , 34 💬
1387 Non-small cell lung cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1388 Non-small cell lung cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1389 Non-small cell lung cancer 💬
3件: BRAF, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1390 Non-small cell lung cancer 💬
3件: BRAF, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1391 Non-small cell lung cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1392 Non-small cell lung cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1393 Non-small cell lung cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1394 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1395 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1396 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1397 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1398 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1399 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1400 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1401 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1402 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1403 Non-small cell lung cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1404 Non-small cell lung cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1405 Non-small cell lung cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1406 Non-small cell lung cancer 💬
1件: RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1407 Non-small cell lung cancer 💬
1件: RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1408 One carbon pool by folate 💬
2件: DHFR, DHFR 💬 Methotrexate 💬 Methotrexate 39件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
1409 One carbon pool by folate 💬
2件: DHFR, DHFR 💬 Methotrexate sodium 💬 Methotrexate 39件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 85, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
1410 Oocyte meiosis 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1411 Oocyte meiosis 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1412 Oocyte meiosis 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1413 Oocyte meiosis 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1414 Oocyte meiosis 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1415 Oocyte meiosis 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1416 Osteoclast differentiation 💬
1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1417 Osteoclast differentiation 💬
1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1418 Osteoclast differentiation 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1419 Osteoclast differentiation 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1420 Osteoclast differentiation 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1421 Osteoclast differentiation 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1422 Osteoclast differentiation 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1423 Osteoclast differentiation 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1424 Osteoclast differentiation 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1425 Osteoclast differentiation 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1426 Osteoclast differentiation 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1427 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1428 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1429 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1430 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1431 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1432 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1433 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1434 Ovarian steroidogenesis 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1435 Oxytocin signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1436 Oxytocin signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1437 Oxytocin signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1438 Oxytocin signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1439 Oxytocin signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1440 Oxytocin signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1441 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1442 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1443 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1444 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1445 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1446 Oxytocin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1447 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1448 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1449 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1450 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1451 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1452 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1453 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1454 Oxytocin signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1455 Oxytocin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1456 Oxytocin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1457 p53 signaling pathway 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1458 Pancreatic cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1459 Pancreatic cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1460 Pancreatic cancer 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1461 Pancreatic cancer 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1462 Pancreatic cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1463 Pancreatic cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1464 Pancreatic cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1465 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1466 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1467 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1468 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1469 Pancreatic cancer 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1470 Pancreatic cancer 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1471 Pancreatic cancer 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1472 Pancreatic cancer 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1473 Pancreatic cancer 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1474 Pancreatic cancer 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1475 Pancreatic cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1476 Pancreatic cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1477 Pancreatic cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1478 Pancreatic cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1479 Pancreatic cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1480 Pancreatic secretion 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1481 Pancreatic secretion 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1482 Pancreatic secretion 💬
1件: CHRM3 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1483 Parathyroid hormone synthesis, secretion and action 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1484 Parathyroid hormone synthesis, secretion and action 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1485 Parathyroid hormone synthesis, secretion and action 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1486 Parathyroid hormone synthesis, secretion and action 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1487 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1488 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1489 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1490 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1491 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1492 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1493 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1494 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1495 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1496 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1497 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1498 Parathyroid hormone synthesis, secretion and action 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1499 Parathyroid hormone synthesis, secretion and action 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
1500 Parkinson disease 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1501 Parkinson disease 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1502 Parkinson disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1503 Parkinson disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1504 Parkinson disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1505 Parkinson disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1506 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1507 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1508 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1509 Pathogenic Escherichia coli infection 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1510 Pathogenic Escherichia coli infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1511 Pathogenic Escherichia coli infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1512 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1513 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1514 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1515 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1516 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1517 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1518 Pathways in cancer 💬
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1519 Pathways in cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬
1520 Pathways in cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 2件:  2 , 34 💬
1521 Pathways in cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1522 Pathways in cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1523 Pathways in cancer 💬
7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1524 Pathways in cancer 💬
7件: BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1525 Pathways in cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1526 Pathways in cancer 💬
7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1527 Pathways in cancer 💬
7件: CSF1R, FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1528 Pathways in cancer 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 29件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1529 Pathways in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1530 Pathways in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1531 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1532 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1533 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1534 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1535 Pathways in cancer 💬
1件: FLT4 💬 Axitinib 💬 Axitinib 1件: 34 💬
1536 Pathways in cancer 💬
1件: FLT4 💬 Cediranib 💬 Cediranib 1件: 34 💬
1537 Pathways in cancer 💬
1件: FLT4 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1538 Pathways in cancer 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1539 Pathways in cancer 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1540 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1541 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1542 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1543 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1544 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1545 Pathways in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1546 Pathways in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1547 Pathways in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1548 Pathways in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1549 Pathways in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1550 Pathways in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1551 Pathways in cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1552 Pathways in cancer 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1553 Pathways in cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1554 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1555 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1556 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1557 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1558 Pathways in cancer 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1559 Pathways in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1560 Pathways in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1561 Pathways of neurodegeneration - multiple diseases 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1562 Pathways of neurodegeneration - multiple diseases 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1563 Pathways of neurodegeneration - multiple diseases 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1564 Pathways of neurodegeneration - multiple diseases 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1565 Pathways of neurodegeneration - multiple diseases 💬
3件: CHRM1, CHRM3, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1566 Pathways of neurodegeneration - multiple diseases 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1567 Pathways of neurodegeneration - multiple diseases 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1568 Pathways of neurodegeneration - multiple diseases 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1569 Pathways of neurodegeneration - multiple diseases 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1570 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1571 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1572 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1573 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1574 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1575 Pathways of neurodegeneration - multiple diseases 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1576 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1577 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1578 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1579 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1580 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1581 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1582 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1583 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1584 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1585 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1586 Pathways of neurodegeneration - multiple diseases 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1587 Pathways of neurodegeneration - multiple diseases 💬
1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1588 Pathways of neurodegeneration - multiple diseases 💬
1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1589 Pathways of neurodegeneration - multiple diseases 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1590 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1591 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1592 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1593 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1594 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: ALK 💬 Brigatinib 💬 Brigatinib 1件: 34 💬
1595 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: ALK 💬 Crizotinib 💬 Crizotinib 2件:  2 , 34 💬
1596 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1597 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1598 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1599 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1600 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1601 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1602 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1603 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1604 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1605 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1606 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1607 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1608 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1609 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1610 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1611 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1612 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1613 Pertussis 💬
5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1614 Pertussis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1615 Pertussis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1616 Phagosome 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1617 Phagosome 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1618 Phagosome 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1619 Phagosome 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1620 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1621 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1622 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1623 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1624 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1625 Phospholipase D signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1626 Phospholipase D signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1627 Phospholipase D signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1628 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1629 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1630 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1631 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1632 Phospholipase D signaling pathway 💬
3件: KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1633 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1634 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1635 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1636 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1637 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1638 Phospholipase D signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1639 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1640 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1641 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1642 PI3K-Akt signaling pathway 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1643 PI3K-Akt signaling pathway 💬
2件: CHRM1, CHRM2 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1644 PI3K-Akt signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1645 PI3K-Akt signaling pathway 💬
9件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1646 PI3K-Akt signaling pathway 💬
1件: CSF3R 💬 Filgrastim 💬 Filgrastim 29件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1647 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1648 PI3K-Akt signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1649 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1650 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1651 PI3K-Akt signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
1652 PI3K-Akt signaling pathway 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1653 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1654 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1655 PI3K-Akt signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1656 PI3K-Akt signaling pathway 💬
7件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1657 PI3K-Akt signaling pathway 💬
7件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1658 PI3K-Akt signaling pathway 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1659 PI3K-Akt signaling pathway 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1660 PI3K-Akt signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1661 PI3K-Akt signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1662 PI3K-Akt signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1663 PI3K-Akt signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1664 PI3K-Akt signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1665 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1666 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1667 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1668 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1669 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1670 PI3K-Akt signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1671 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1672 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1673 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1674 PI3K-Akt signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1675 PI3K-Akt signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1676 Platelet activation 💬
1件: PTGS1 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1677 Platelet activation 💬
1件: PTGS1 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1678 Platelet activation 💬
1件: PTGS1 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1679 Platelet activation 💬
1件: PTGS1 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1680 Platelet activation 💬
1件: PTGS1 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1681 Platelet activation 💬
1件: PTGS1 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1682 Platelet activation 💬
1件: PTGS1 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1683 Prion disease 💬
4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1684 Prion disease 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1685 Prion disease 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1686 Prion disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1687 Prion disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1688 Prion disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1689 Prion disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1690 Progesterone-mediated oocyte maturation 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1691 Progesterone-mediated oocyte maturation 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1692 Progesterone-mediated oocyte maturation 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1693 Progesterone-mediated oocyte maturation 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1694 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1695 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1696 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1697 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1698 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1699 Progesterone-mediated oocyte maturation 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1700 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1701 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1702 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1703 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1704 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1705 Prolactin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1706 Prolactin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1707 Prolactin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1708 Propanoate metabolism 💬
1件: ABAT 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
1709 Propanoate metabolism 💬
1件: ABAT 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
1710 Propanoate metabolism 💬
1件: ABAT 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
1711 Prostate cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1712 Prostate cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1713 Prostate cancer 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1714 Prostate cancer 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1715 Prostate cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1716 Prostate cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1717 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1718 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1719 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
1720 Prostate cancer 💬
2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1721 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1722 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1723 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1724 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1725 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1726 Prostate cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1727 Prostate cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1728 Prostate cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1729 Prostate cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1730 Prostate cancer 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1731 Prostate cancer 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1732 Prostate cancer 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1733 Prostate cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1734 Prostate cancer 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1735 Proteoglycans in cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1736 Proteoglycans in cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1737 Proteoglycans in cancer 💬
3件: BRAF, KDR, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1738 Proteoglycans in cancer 💬
3件: BRAF, KDR, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1739 Proteoglycans in cancer 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1740 Proteoglycans in cancer 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1741 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1742 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1743 Proteoglycans in cancer 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
1744 Proteoglycans in cancer 💬
3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1745 Proteoglycans in cancer 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1746 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1747 Proteoglycans in cancer 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1748 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1749 Proteoglycans in cancer 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1750 Proteoglycans in cancer 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1751 Proteoglycans in cancer 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1752 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1753 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1754 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1755 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1756 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1757 Proteoglycans in cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1758 Proteoglycans in cancer 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1759 Proteoglycans in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1760 Proteoglycans in cancer 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1761 Proteoglycans in cancer 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1762 Proteoglycans in cancer 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1763 Proteoglycans in cancer 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1764 Proteoglycans in cancer 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1765 Proteoglycans in cancer 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1766 Purine metabolism 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
1767 Purine metabolism 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
1768 Pyrimidine metabolism 💬
1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
1769 Pyrimidine metabolism 💬
1件: RRM1 💬 Fludarabine 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
1770 Rap1 signaling pathway 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1771 Rap1 signaling pathway 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1772 Rap1 signaling pathway 💬
6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1773 Rap1 signaling pathway 💬
6件: BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1774 Rap1 signaling pathway 💬
7件: CSF1R, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1775 Rap1 signaling pathway 💬
7件: CSF1R, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1776 Rap1 signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1777 Rap1 signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1778 Rap1 signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1779 Rap1 signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1780 Rap1 signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1781 Rap1 signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1782 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1783 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1784 Rap1 signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1785 Rap1 signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1786 Rap1 signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1787 Rap1 signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1788 Rap1 signaling pathway 💬
2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1789 Rap1 signaling pathway 💬
3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1790 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1791 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1792 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1793 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1794 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1795 Rap1 signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1796 Rap1 signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1797 Rap1 signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1798 Ras signaling pathway 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1799 Ras signaling pathway 💬
3件: ABL1, KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1800 Ras signaling pathway 💬
4件: ABL1, KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1801 Ras signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1802 Ras signaling pathway 💬
8件: CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1803 Ras signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1804 Ras signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1805 Ras signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1806 Ras signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1807 Ras signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1808 Ras signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1809 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
1810 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
1811 Ras signaling pathway 💬
3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1812 Ras signaling pathway 💬
6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1813 Ras signaling pathway 💬
6件: FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1814 Ras signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1815 Ras signaling pathway 💬
2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1816 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1817 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1818 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1819 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1820 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1821 Ras signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1822 Ras signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1823 Ras signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1824 Regulation of actin cytoskeleton 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1825 Regulation of actin cytoskeleton 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1826 Regulation of actin cytoskeleton 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1827 Regulation of actin cytoskeleton 💬
3件: BRAF, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1828 Regulation of actin cytoskeleton 💬
5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1829 Regulation of actin cytoskeleton 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1830 Regulation of actin cytoskeleton 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1831 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1832 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1833 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1834 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1835 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1836 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1837 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1838 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1839 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1840 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1841 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1842 Regulation of actin cytoskeleton 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1843 Regulation of actin cytoskeleton 💬
1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1844 Regulation of actin cytoskeleton 💬
1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1845 Regulation of actin cytoskeleton 💬
2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
1846 Regulation of actin cytoskeleton 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1847 Regulation of actin cytoskeleton 💬
2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1848 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1849 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1850 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1851 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1852 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1853 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1854 Regulation of lipolysis in adipocytes 💬
2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1855 Regulation of lipolysis in adipocytes 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1856 Relaxin signaling pathway 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1857 Relaxin signaling pathway 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1858 Relaxin signaling pathway 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1859 Relaxin signaling pathway 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1860 Relaxin signaling pathway 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1861 Relaxin signaling pathway 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1862 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1863 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1864 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1865 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1866 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1867 Relaxin signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1868 Relaxin signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1869 Relaxin signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1870 Relaxin signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1871 Relaxin signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1872 Renal cell carcinoma 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1873 Renal cell carcinoma 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1874 Renal cell carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1875 Renal cell carcinoma 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1876 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1877 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1878 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1879 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1880 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1881 Renal cell carcinoma 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1882 Renal cell carcinoma 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
1883 Renal cell carcinoma 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
1884 Renal cell carcinoma 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1885 Renal cell carcinoma 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1886 Retrograde endocannabinoid signaling 💬
16件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1887 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1888 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1889 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1890 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1891 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1892 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1893 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1894 Retrograde endocannabinoid signaling 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1895 Rheumatoid arthritis 💬
5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1896 Rheumatoid arthritis 💬
1件: FLT1 💬 Axitinib 💬 Axitinib 1件: 34 💬
1897 Rheumatoid arthritis 💬
1件: FLT1 💬 Cediranib 💬 Cediranib 1件: 34 💬
1898 Rheumatoid arthritis 💬
1件: FLT1 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
1899 Rheumatoid arthritis 💬
1件: FLT1 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
1900 Rheumatoid arthritis 💬
1件: FLT1 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
1901 Rheumatoid arthritis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1902 Rheumatoid arthritis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1903 Rheumatoid arthritis 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
1904 Rheumatoid arthritis 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
1905 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1906 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1907 RIG-I-like receptor signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1908 Salivary secretion 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
1909 Salivary secretion 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
1910 Salivary secretion 💬
1件: CHRM3 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
1911 Salmonella infection 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1912 Salmonella infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1913 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1914 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1915 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1916 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1917 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1918 Salmonella infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1919 Salmonella infection 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1920 Salmonella infection 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1921 Salmonella infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1922 Salmonella infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
1923 Salmonella infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
1924 Salmonella infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
1925 Salmonella infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
1926 Serotonergic synapse 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
1927 Serotonergic synapse 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
1928 Serotonergic synapse 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1929 Serotonergic synapse 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1930 Serotonergic synapse 💬
3件: GABRB, GABRB, GABRB 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
1931 Serotonergic synapse 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1932 Serotonergic synapse 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1933 Serotonergic synapse 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1934 Serotonergic synapse 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1935 Serotonergic synapse 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1936 Serotonergic synapse 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1937 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1938 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1939 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1940 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1941 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1942 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1943 Serotonergic synapse 💬
2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1944 Serotonergic synapse 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1945 Shigellosis 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
1946 Shigellosis 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
1947 Shigellosis 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
1948 Shigellosis 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
1949 Shigellosis 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
1950 Shigellosis 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
1951 Shigellosis 💬
2件: IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1952 Shigellosis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1953 Shigellosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1954 Shigellosis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1955 Shigellosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1956 Shigellosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1957 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1958 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1959 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1960 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1961 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1962 Signaling pathways regulating pluripotency of stem cells 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1963 Signaling pathways regulating pluripotency of stem cells 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1964 Signaling pathways regulating pluripotency of stem cells 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1965 Small cell lung cancer 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1966 Small cell lung cancer 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
1967 Small cell lung cancer 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
1968 Small cell lung cancer 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
1969 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1970 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1971 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1972 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1973 Small cell lung cancer 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
1974 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1975 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1976 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1977 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
1978 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1979 Sphingolipid signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
1980 Sphingolipid signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
1981 Sphingolipid signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
1982 Sphingolipid signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1983 Sphingolipid signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1984 Sphingolipid signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1985 Spinocerebellar ataxia 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1986 Spinocerebellar ataxia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
1987 Spinocerebellar ataxia 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
1988 Staphylococcus aureus infection 💬
1件: IL10 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1989 Synaptic vesicle cycle 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1990 Synaptic vesicle cycle 💬
2件: SLC6A2, SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
1991 Systemic lupus erythematosus 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1992 Systemic lupus erythematosus 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
1993 Systemic lupus erythematosus 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
1994 T cell receptor signaling pathway 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
1995 T cell receptor signaling pathway 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1996 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
1997 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
1998 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
1999 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2000 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2001 T cell receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2002 T cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2003 T cell receptor signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2004 T cell receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2005 T cell receptor signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2006 Taste transduction 💬
1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
2007 Taste transduction 💬
1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
2008 Taste transduction 💬
1件: CHRM3 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
2009 Taste transduction 💬
6件: GABRA, GABRA, GABRA, GABRA, GABRA, GABRA 💬 Propofol 💬 Propofol 10件:  3 ,  6 , 21, 22, 34, 46, 70, 97, 98, 296 💬
2010 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lamotrigine 💬 Lamotrigine 6件: 13, 34, 38, 113, 114, 144 💬
2011 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
2012 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
2013 Taste transduction 💬
3件: SCN2A, SCN3A, SCN9A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
2014 Taurine and hypotaurine metabolism 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2015 Taurine and hypotaurine metabolism 💬
2件: E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2016 Taurine and hypotaurine metabolism 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2017 Terpenoid backbone biosynthesis 💬
2件: FNTA, FNTB 💬 Tipifarnib 💬 Tipifarnib 1件: 34 💬
2018 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
2019 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
2020 TGF-beta signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2021 TGF-beta signaling pathway 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2022 TGF-beta signaling pathway 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2023 Th17 cell differentiation 💬
2件: IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2024 Th17 cell differentiation 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2025 Th17 cell differentiation 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2026 Th17 cell differentiation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2027 Th17 cell differentiation 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2028 Thermogenesis 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2029 Thermogenesis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2030 Thermogenesis 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2031 Thyroid cancer 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2032 Thyroid cancer 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
2033 Thyroid cancer 💬
2件: BRAF, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2034 Thyroid cancer 💬
2件: BRAF, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2035 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2036 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2037 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2038 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2039 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2040 Thyroid cancer 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2041 Thyroid cancer 💬
1件: RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2042 Thyroid cancer 💬
1件: RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2043 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2044 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2045 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2046 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2047 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2048 Thyroid hormone signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2049 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2050 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2051 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2052 Thyroid hormone signaling pathway 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2053 Thyroid hormone signaling pathway 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2054 Tight junction 💬
1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
2055 Tight junction 💬
1件: ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
2056 Tight junction 💬
1件: ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
2057 Tight junction 💬
1件: ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
2058 Tight junction 💬
1件: ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
2059 TNF signaling pathway 💬
4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2060 TNF signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2061 TNF signaling pathway 💬
1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2062 TNF signaling pathway 💬
1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2063 TNF signaling pathway 💬
1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2064 TNF signaling pathway 💬
1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2065 TNF signaling pathway 💬
1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2066 TNF signaling pathway 💬
1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2067 TNF signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
2068 TNF signaling pathway 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
2069 TNF signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
2070 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2071 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2072 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2073 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2074 TNF signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2075 TNF signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2076 Toll-like receptor signaling pathway 💬
3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2077 Toll-like receptor signaling pathway 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2078 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2079 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2080 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2081 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2082 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2083 Toll-like receptor signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2084 Toll-like receptor signaling pathway 💬
1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
2085 Toll-like receptor signaling pathway 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2086 Toxoplasmosis 💬
2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2087 Toxoplasmosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2088 Toxoplasmosis 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2089 Transcriptional misregulation in cancer 💬
3件: CSF1R, FLT1, FLT3 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2090 Transcriptional misregulation in cancer 💬
3件: CSF1R, FLT1, FLT3 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2091 Transcriptional misregulation in cancer 💬
1件: FLT1 💬 Axitinib 💬 Axitinib 1件: 34 💬
2092 Transcriptional misregulation in cancer 💬
1件: FLT1 💬 Cediranib 💬 Cediranib 1件: 34 💬
2093 Transcriptional misregulation in cancer 💬
1件: FLT1 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
2094 Transcriptional misregulation in cancer 💬
1件: FLT3 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2095 Transcriptional misregulation in cancer 💬
1件: FLT3 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2096 Transcriptional misregulation in cancer 💬
1件: IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2097 Transcriptional misregulation in cancer 💬
1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2098 Transcriptional misregulation in cancer 💬
1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
2099 Transcriptional misregulation in cancer 💬
1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
2100 Tuberculosis 💬
5件: IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2101 Tuberculosis 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2102 Tuberculosis 💬
1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2103 Tuberculosis 💬
1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2104 Tuberculosis 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2105 Tuberculosis 💬
1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
2106 Type I diabetes mellitus 💬
2件: E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2107 Type I diabetes mellitus 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2108 Type I diabetes mellitus 💬
2件: E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2109 Type I diabetes mellitus 💬
3件: IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2110 Type I diabetes mellitus 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2111 Type I diabetes mellitus 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2112 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2113 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2114 Type II diabetes mellitus 💬
1件: CACNA1G 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2115 Type II diabetes mellitus 💬
1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2116 Type II diabetes mellitus 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2117 Type II diabetes mellitus 💬
1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
2118 Type II diabetes mellitus 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2119 Type II diabetes mellitus 💬
1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2120 Type II diabetes mellitus 💬
1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2121 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2122 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2123 Valine, leucine and isoleucine degradation 💬
1件: ABAT 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
2124 Vascular smooth muscle contraction 💬
1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2125 Vascular smooth muscle contraction 💬
1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
2126 Vascular smooth muscle contraction 💬
2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2127 Vascular smooth muscle contraction 💬
2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2128 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2129 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2130 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2131 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2132 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2133 Vascular smooth muscle contraction 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2134 VEGF signaling pathway 💬
1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
2135 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
2136 VEGF signaling pathway 💬
1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
2137 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
2138 VEGF signaling pathway 💬
1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
2139 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2140 VEGF signaling pathway 💬
1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2141 VEGF signaling pathway 💬
2件: KDR, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
2142 VEGF signaling pathway 💬
2件: KDR, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
2143 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2144 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2145 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2146 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2147 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2148 VEGF signaling pathway 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2149 VEGF signaling pathway 💬
1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
2150 VEGF signaling pathway 💬
1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
2151 VEGF signaling pathway 💬
1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
2152 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2153 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2154 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2155 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2156 VEGF signaling pathway 💬
1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
2157 VEGF signaling pathway 💬
1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
2158 VEGF signaling pathway 💬
1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
2159 Viral carcinogenesis 💬
2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
2160 Viral myocarditis 💬
1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2161 Viral myocarditis 💬
1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2162 Viral myocarditis 💬
1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
2163 Viral protein interaction with cytokine and cytokine receptor 💬
4件: CCL2, IL10, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2164 Viral protein interaction with cytokine and cytokine receptor 💬
1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
2165 Viral protein interaction with cytokine and cytokine receptor 💬
1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
2166 Viral protein interaction with cytokine and cytokine receptor 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2167 Viral protein interaction with cytokine and cytokine receptor 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
2168 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
2169 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
2170 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
2171 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
2172 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
2173 Virion - Hepatitis viruses 💬
1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
2174 Yersinia infection 💬
5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
2175 Yersinia infection 💬
2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
2176 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
2177 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
2178 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
2179 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
2180 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2181 Yersinia infection 💬
2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
2182 Yersinia infection 💬
1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬